What CBD and COVID-19 Studies Could Mean for the Industry
These recent studies demonstrate the continued potential of CBD. Valuable cannabinoids, including CBDa and CBGa, may help to prevent or even treat COVID-19 infections. While they aren’t definitive, they could pave the way for clinical trials to determine more concrete answers.
For now, scientists warn not to self-treat with over-the-counter CBD products. While high-quality CBD products may be a good addition to an overall wellness routine, we don’t yet know how, for example, CBD oil and COVID-19 interact. As such, you should continue to protect yourself in ways that we know work. With more research and data, we will get a fuller picture on the effects of hemp compounds on COVID-19.
Sources:
-
van Breemen, R. B., Muchiri, R. N., Bates, T. A., Weinstein, J. B., Leier, H. C., Farley, S., & Tafesse, F. G. (2022). Cannabinoids Block Cellular Entry of SARS-CoV-2 and the Emerging Variants. Journal of natural products, 85(1), 176–184. https://doi.org/10.1021/acs.jnatprod.1c00946
-
Nguyen, L., Yang, D., Nicolaescu, V., Best, T.J., Gula, H., Saxena, D., Gabbard, J.D., Chen, S., Ohtsuki, T., Friesen, J.B., Drayman, N., Mohamed, A., Dann, C., Silva, D., Robinson-Mailman, L., Valdespino, A., Stock, L., Suárez, E., Jones, K., … Rosner, M.R. (2022). Cannabidol inhibits SARS-CoV-2 replication through induction of the host ER stress response and innate immune responses. Science Advances. https://www.science.org/doi/10.1126/sciadv.abi6110
|